World's Best Scientists 2026 revealed!
Elizabeth A. Eisenhauer

Elizabeth A. Eisenhauer

D-Index & Metrics

Medicine

D-Index
88
Citations
112994
World Ranking
12873
National Ranking
526

Elizabeth A. Eisenhauer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Elizabeth A. Eisenhauer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 352 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Elizabeth A. Eisenhauer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Elizabeth A. Eisenhauer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Elizabeth A. Eisenhauer is affiliated with Queen's University in Canada. Their research spans the intersection of medicine, economics, econometrics, and finance, with a total of 51 publications in Medicine and 22 in Economics, Econometrics and Finance.

Their subfields of study include Economics and Econometrics, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, and Statistics and Probability. Their research topics cover Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations and Quality of Life, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Statistical Methods in Clinical Trials, and Global Cancer Incidence and Screening.

Elizabeth A. Eisenhauer has published multiple papers in notable venues. Frequent publication venues include JAMA Oncology, The Lancet Oncology, European Journal of Cancer, Current Oncology, and CHEST Journal.

Some recent publications include:

  • Evolution of the Randomized Clinical Trial in the Era of Precision Oncology, 2021, JAMA Oncology
  • Common Sense Oncology: outcomes that matter, 2023, The Lancet Oncology
  • Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer, 2023, European Journal of Cancer
  • Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class, 2022, JAMA Oncology
  • Medical students need artificial intelligence and machine learning training, 2021, Nature Biotechnology

Elizabeth has collaborated frequently with a group of coauthors, with the highest number of joint publications involving Bishal Gyawali and Christopher M. Booth, each having 14 coauthored works. Other frequent collaborators include Michael Brundage, Ian F. Tannock, and Brooke E. Wilson.

Best Publications

  • New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

    Elizabeth Eisenhauer;Patrick Therasse;Jan Bogaerts;L.H. Schwartz

  • Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

    Roger Stupp;Warren P. Mason;Martin J. van den Bent;Michael Weller

  • New guidelines to evaluate the response to treatment in solid tumors

    Patrick Therasse;Susan G. Arbuck;Elizabeth A. Eisenhauer;Jantien Wanders

  • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

    Roger Stupp;Monika E. Hegi;Warren P. Mason;Martin J. van den Bent

  • Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

    Jacobus Pfisterer;Marie Plante;Ignace Vergote;Andreas du Bois

  • Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

    Edward L. Korn;Ping Yu Liu;Sandra J. Lee;Judith Anne W. Chapman

  • European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

    E A Eisenhauer;W W ten Bokkel Huinink;K D Swenerton;L Gianni

  • Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis.

    Astec;P Blake;Ann Marie Swart

  • Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

    Gordon John Sampson Rustin;Ignace Vergote;Elizabeth Eisenhauer;Eric Pujade-Lauraine

  • Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

    Thierry Gorlia;Martin J van den Bent;Monika E Hegi;Monika E Hegi;René O Mirimanoff

  • 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

    A du Bois;M Quinn;T Thigpen;J Vermorken

  • Measuring Response in Solid Tumors: Unidimensional Versus Bidimensional Measurement

    Keith James;Elizabeth Eisenhauer;Michaele Christian;Monica Terenziani

  • Advanced epithelial ovarian cancer: 1998 consensus statements.

    J. S. Berek;K. Bertelsen;A. Du Bois;M. F. Brady

  • Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)

    Gordon J. S. Rustin;Michael Quinn;Tate Thigpen;Andreas du Bois

  • Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

    Amit M. Oza;Laurie Elit;Ming-Sound Tsao;Suzanne Kamel-Reid

  • Progression-Free Survival: Meaningful or Simply Measurable?

    Christopher M. Booth;Elizabeth A. Eisenhauer

  • Health-related quality of life in patients with glioblastoma: a randomised controlled trial

    Martin J B Taphoorn;Roger Stupp;Corneel Coens;David Osoba

  • Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients

    E. A. Eisenhauer;J. B. Vermorken;M. van Glabbeke

  • The taxoids. Comparative clinical pharmacology and therapeutic potential.

    Elizabeth A. Eisenhauer;Jan B. Vermorken

  • European-Canadian randomized trial of Paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

    Elizabeth A. Eisenhauer;Wim W. ten Bokkel Huinink;Kenneth D. Swenerton;Luca Gianni

Frequent Co-Authors

Dongsheng Tu
Dongsheng Tu Queen's University
Amit M. Oza
Amit M. Oza Princess Margaret Cancer Centre
Kim N. Chi
Kim N. Chi BC Cancer Agency
Lesley Seymour
Lesley Seymour Queen's University
Suzanne Kamel-Reid
Suzanne Kamel-Reid University Health Network
Janet Dancey
Janet Dancey Queen's University
Ming-Sound Tsao
Ming-Sound Tsao Princess Margaret Cancer Centre
Jan B. Vermorken
Jan B. Vermorken University of Antwerp
Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto
Jeremy A. Squire
Jeremy A. Squire Universidade de São Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine also opens doors to many related fields through flexible online study options. For those interested in the business side of healthcare, a healthcare administration degree online accredited program can lead to leadership or management roles in hospitals and clinics.

Registered nurses aiming for advanced practice can benefit from specialized bridge programs, such as rn to fnp bridge programs. These programs make it possible to become a family nurse practitioner, enhancing both clinical skills and earning potential.

With public interest in wellness and preventive care rising, online degrees in nutrition offer a route to professional roles in dietetics, health education, and research.

If you are drawn to high-level leadership in the healthcare industry, online mha programs cahme accredited allow you to earn a respected qualification needed for executive and administrative positions.

Each pathway provides the opportunity to impact patient care and healthcare systems—even outside traditional medical practice—while offering the convenience and flexibility of online learning.

Best Scientists Citing Elizabeth A. Eisenhauer

Trending Scientists

Recently Published Articles